Skip to content

Effect of local anesthetic baricity on control of maternal hypotension after spinal anesthesia for cesarean section

Effect of Baricity of Bupivacaine on the Maternal Hemodynamics during Spinal Anesthesia for Cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201401287013N7
Enrollment
84
Registered
2014-02-12
Start date
2013-12-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension after spinal anesthesia. Hypotension due to drugs

Interventions

Intervention 1: In the study group (n=42)0.5 % of isobaric bupivacaine 10 mg with fentanyl 15 µg during spinal anesthesia is administered. Intervention 2: ]n the control group (n=42) hyperbaric bupiva
Prevention
Treatment - Drugs
In the study group (n=42)0.5 % of isobaric bupivacaine 10 mg with fentanyl 15 µg during spinal anesthesia is administered.
]n the control group (n=42) hyperbaric bupivacaine 10 mg with fentanyl 15 µg during spinal anesthesia is administered.

Sponsors

Research Vice Chancellor of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ASA class I; term pregnancy; aged 18-40 years; scheduled for elective cesarean; scheduled for spinal anesthesia Exclusion criteria: weight >85kg; Height >170cm and < 150cm; contraindication for spinal anesthesia; history of systemic or psychopathic disorders; preeclampsia or eclampsia; allergy to local anesthetics

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: Baseline and every 2 minutes after spinal anesthesia to 10 min and then every 5 min to end of surgery. Method of measurement: Manometer.

Secondary

MeasureTime frame
Total dose of vasoconstrictors. Timepoint: After spinal anesthesia to end of operation. Method of measurement: Doses of medicatins by mg or ug.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Simin Atashkhoyi

Tabriz University of Medical Sciences

satashkhoyi@gmail.comsiminatashkhoii@yahoo.com+98 41 1553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026